Home/Filings/4/0001104659-23-124723
4//SEC Filing

Quiroga Cortes Isidoro Alfonso 4

Accession 0001104659-23-124723

CIK 0001856725other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:29 PM ET

Size

7.1 KB

Accession

0001104659-23-124723

Insider Transaction Report

Form 4
Period: 2023-11-24
Transactions
  • Sale

    Class A Common Stock

    2023-11-24$2.01/sh5,265,165$10,582,9828,400 total(indirect: By Partnership)
Transactions
  • Sale

    Class A Common Stock

    2023-11-24$2.01/sh5,265,165$10,582,9828,400 total(indirect: By Partnership)
Footnotes (2)
  • [F1]The Reporting Person sold 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price.
  • [F2]Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001854578

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:29 PM ET
Size
7.1 KB